Small Business

Though not as generous as the Senate's package, House Speaker Robert DeLeo's proposal to raise the minimum wage to $10.50 an hour would still give Massachusetts the highest wage floor in the country. However, it remains to be seen whether it will be enough to stop ballot activists from pursuing more in November.

A little over five years ago, Peter Rucinski couldn't have told you the first thing about yoga.

Massachusetts is used to being on the cutting edge. In politics and social change or in technology...

Attorney General Martha Coakley has joined 41 other attorneys general in supporting federal legislation against “patent trolls” to “address frivolous and abusive patent lawsuits that threaten small, start-up businesses.”

Milford biotech startup Prothelia Inc. announced it has entered into an agreement with a Connecticut-based drug company to further develop Prothelia's clinical-stage treatment for the rare form of muscular dystrophy known as MCD1A. Alexion Pharmaceuticals Inc., which specializes in treatments for rare diseases, will have an option to acquire Prothelia and license its clinical-state treatment, Laminin-111, after entering into a “strategic agreement” with Prothelia and its research partner, the University of Nevada Reno (UNR), according to a statement from Prothelia.

(From Feb. 17 print edition) An influx of new technology has left companies scrambling to determine how best to dispose of outdated machines and the information contained within them.

The Massachusetts health care industry has entered an era of uncharted territory, now that the state can force providers to spend tens of thousands of their own money on information technology infrastructure to help them share patient records more easily.

The decision to take a company public isn't an easy one, said Paul Brannelly, senior vice president of finance and administration at Karyopharm Therapeutics in Natick. The money and time spent on activities related to public trading are considerable, according to Brannelly. Being public somewhat limits executives' ability to make quick business decisions. But Karyopharm, a clinical-stage drug company that is developing treatments for solid tumors as well as cancers of the blood, saw pursuing an initial public offering (IPO) this fall as an opportunity to shore up financing as it continues the lengthy clinical trial process that it hopes will lead to approval from the U.S. Food and Drug Administration (FDA).

Charter Business, a division of Charter Communications, Inc., will offer faster Internet download speeds to commercial customers in Central Massachusetts, the company announced Monday.

This fall, Whitcomb House, a 55-unit, family-owned assisted-living residence in Milford, was quietly acquired by one of...